Evidence map›Paper›PMID 40563030›Full record

ArticleAnnals of surgical oncology2025

Surgical and Oncologic Outcomes of Tumescence and Sharp Dissection Versus Electrocautery Dissection in Minimal-Access Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction: A Real-World Retrospective Cohort Study.

Xinyu Ou, Zhihan Liu, Caigang Liu, Kun Wang, Pusheng Zhang, Xuli Meng, Wei Wei, Yuan Shi, Shu Liu, Taolang Li and 13 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Complications, patient satisfaction, clinical outcomes, and aesthetic outcomes of nipple-sparingTranslational breast cancer research : a journal focusing on translational research in breast cancer · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Xinyu OuBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Zhihan LiuBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Caigang LiuDepartment of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Kun WangDepartment of Breast Oncology, Guangdong Provincial People's Hospital, Guangzhou, China.
Pusheng ZhangDepartment of Breast Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xuli MengGeneral Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wei WeiDepartment of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
Yuan ShiDepartment of Breast Surgery, Anyang Tumor Hospital, Anyang, China.
Shu LiuDepartment of Breast Surgery, The Affiliated Hospital of Guizhou Medical University, Guizhou, China.
Taolang LiDepartment of General Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Tai XuDepartment of Breast Surgery, Meizhou People's Hospital, Meizhou, China.
Wei TangDepartment of Breast Surgery, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Chenlu LiuBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Jiangtao LiBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Zixuan LiBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Jianli ZhaoBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Yan NieBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
GuangLei ChenDepartment of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Zhenye LvGeneral Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital of Hangzhou Medical College, Hangzhou, China.
Xiaoling LiuDepartment of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
Yandan YaoBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Yiwen LuBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. luyw8@mail.sysu.edu.cn.
Shicheng SuBreast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. sushch@mail.sysu.edu.cn.

Funding

Science and Technology Program of Guangzhou 202103000070Science and Technology Program of Guangzhou 202201020479Sun Yat-Sen Memorial Hospital Clinical Research 5010 Program SYS-5010-202507the National Key Research and Development Program of China 2023YFC3404500the Natural Science Foundation of China 82125017the Natural Science Foundation of China 82173064the Natural Science Foundation of China 82322030the Natural Science Foundation of China 92057210the Natural Science Foundation of China 92359302
6 · The paper itself

Abstract

backgroundMinimal-access nipple-sparing mastectomy (NSM) with immediate prosthesis breast reconstruction results in better cosmetic outcomes than conventional operation. However, the impact of skin flap development techniques on postoperative complications and long-term oncologic safety is largely unknown. This report describes the surgical and oncologic outcomes of tumescence and sharp dissection compared with electrocautery dissection.

methodsIn this real-world retrospective cohort study, 5436 individuals undergoing NSM from 12 centers in China were identified. After exclusions and propensity score-matching, the study included 1252 patients who underwent minimal-access NSM with immediate prosthesis breast reconstruction between January 2016 and December 2022. Perioperative parameters, postsurgical complications, and long-term survival were analyzed.

resultsOf the 1252 patients, 313 (25 %) underwent tumescence and sharp dissection, and 939 (75 %) underwent electrocautery dissection. The patients in the tumescence and sharp dissection group had significantly lower rates of necrotic complications (5.8 % vs 13.0 %; p = 0.001), infection (2.6 % vs 5.6 %; p = 0.041), and implant loss (0.3 % vs 2.2 %; p = 0.025) than those receiving electrocautery dissection, with a significantly shorter operation time (median, 177 min; interquartile range [IQR], 132-219 min vs 201 min; IQR, 143-249 min; p < 0.001). The two groups did not differ significantly in 5-year overall survival (p = 0.938) or disease-free survival (p = 0.893).

conclusionTumescence and sharp dissection was associated with fewer postoperative complications and a shorter operation time than electrocautery dissection for breast cancer patients receiving minimal-access NSM with immediate prosthesis breast reconstruction, and showed no significant difference in long-term survival.

Indexed as

Breast NeoplasmsDissectionElectrocoagulationMammaplastyMinimally Invasive Surgical ProceduresNipplesPostoperative ComplicationsAdultFemaleFollow-Up StudiesHumansMastectomyMiddle AgedOrgan Sparing TreatmentsPrognosisRetrospective StudiesImmediate prosthesis breast reconstructionMinimal-access breast surgeryNipple-sparing mastectomySkin flap developmentSurgical outcomes

Identifiers

PMID40563030
PMCPMC12317917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.